This document has not been cited yet.

1. Ahuja, V., Alvarez, C. A., & Staats, B. R. (2020). Maintaining continuity in service: An empirical examination of primary care physicians. Manufacturing & Service Operations Management, 22(5), 1088–1106.

2. Ali, M. M., Dowd, W. N., Classen, T., Mutter, R., & Novak, S. P. (2017). Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health. Addictive Behaviors, 69, 65–77.
   Paper not yet in RePEc: Add citation now
   

3. Alpert, A., Powell, D., & Pacula, R. L. (2018). Supply‐side drug policy in the presence of substitutes: Evidence from the introduction of abuse‐deterrent opioids. American Economic Journal: Economic Policy, 10(4), 1–35.

4. Amarasingham, R., Moore, B. J., Tabak, Y. P., Drazner, M. H., Clark, C. A., Zhang, S., Reed, W. G., Swanson, T. S., Ma, Y., & Halm, E. A. (2010). An automated model to identify heart failure patients at risk for 30‐day readmission or death using electronic medical record data. Medical Care, 48(11), 981–988.
   Paper not yet in RePEc: Add citation now
   
5. Angst, C. M., Devaraj, S., Queenan, C. C., & Greenwood, B. (2011). Performance effects related to the sequence of integration of healthcare technologies. Production and Operations Management, 20(3), 319–333.
   Paper not yet in RePEc: Add citation now
   
6. Bao, Y., Pan, Y., Taylor, A., Radakrishnan, S., Luo, F., Pincus, H. A., & Schackman, B. R. (2016). Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Affairs, 35(6), 1045–1051.
   Paper not yet in RePEc: Add citation now
   
7. Bao, Y., Wen, K., Johnson, P., Jeng, P. J., Meisel, Z. F., & Schackman, B. R. (2018). Assessing the impact of state policies for prescription drug monitoring programs on high‐risk opioid prescriptions. Health Affairs, 37(10), 1596–1604.
   Paper not yet in RePEc: Add citation now
   

8. Bardhan, I., Oh, J.‐h., Zheng, Z., & Kirksey, K. (2015). Predictive analytics for readmission of patients with congestive heart failure. Information Systems Research, 26(1), 19–39.

9. Ben‐Zion, R., Pliskin, N., & Fink, L. (2014). Critical success factors for adoption of electronic health record systems: Literature review and prescriptive analysis. Information Systems Management, 31(4), 296–312.
   Paper not yet in RePEc: Add citation now
   
10. Brandeis PDMP CoE. (2016). Mandating PDMP participation by medical providers: current status and experience in selected states. Prescription Drug Monitoring Program Center of Excellence at Brandeis. https://www.ojp.gov/pdffiles1/bja/247134.pdf.
    Paper not yet in RePEc: Add citation now
    

11. Buchmueller, T. C., & Carey, C. (2018). The effect of prescription drug monitoring programs on opioid utilization in Medicare. American Economic Journal: Economic Policy, 10(1), 77–112.

12. Buntin, M. B., Burke, M. F., Hoaglin, M. C., & Blumenthal, D. (2011). The benefits of health information technology: A review of the recent literature shows predominantly positive results. Health Affairs, 30(3), 464–471.
    Paper not yet in RePEc: Add citation now
    
13. CDC. (2017). Integrating & Expanding Prescription Drug Monitoring Program data: Lessons from nine states. Centers for Disease Control and Prevention. 2017. http://www.cdc.gov/drugoverdose/pdf/pehriie_report‐a.pdf.
    Paper not yet in RePEc: Add citation now
    
14. CDC. (2018). Wide‐ranging online data for epidemiologic research (WONDER). CDC, National Center for Health Statistics. http://wonder.cdc.gov.
    Paper not yet in RePEc: Add citation now
    
15. Center for Behavioral Health Statistics and Quality. (2018). 2017 National Survey on Drug Use and Health: Detailed tables. Substance Abuse and Mental Health Services Administration.
    Paper not yet in RePEc: Add citation now
    
16. Chaudhry, B., Wang, J., Wu, S., Maglione, M., Mojica, W., Roth, E., Morton, S. C., & Shekelle, P. G. (2006). Systematic review: Impact of health information technology on quality, efficiency, and costs of medical care. Annals of Internal Medicine, 144(10), 742–752.
    Paper not yet in RePEc: Add citation now
    
17. Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012). Effect of abuse‐deterrent formulation of oxycontin. New England Journal of Medicine, 367(2), 187–189.
    Paper not yet in RePEc: Add citation now
    
18. Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the united states: A retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821–826.
    Paper not yet in RePEc: Add citation now
    
19. Compton, W. M., Boyle, M., & Wargo, E. (2015). Prescription opioid abuse: Problems and responses. Preventive Medicine, 80, 5–9.
    Paper not yet in RePEc: Add citation now
    
20. Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016). Relationship between nonmedical prescription‐opioid use and heroin use. New England Journal of Medicine, 374(2), 154–163.
    Paper not yet in RePEc: Add citation now
    
21. Conlon, C. T., & Rao, N. (2015). The Price of liquor is too damn high: Alcohol taxation and market structure. NYU Wagner Research Paper. https://doi.org/10.2139/ssrn.2610118.
    Paper not yet in RePEc: Add citation now
    

22. Conlon, C. T., & Rao, N. L. (2020). Discrete prices and the incidence and efficiency of excise taxes. American Economic Journal: Economic Policy, 12(4), 111–43.

23. Crost, B., & Guerrero, S. (2012). The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age. Journal of Health Economics, 31(1), 112–121.

24. Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher‐Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the united states. New England Journal of Medicine, 372(3), 241–248.
    Paper not yet in RePEc: Add citation now
    

25. Deiana, C., & Giua, L. (2021). The intended and unintended effects of opioid policies on prescription opioids and crime. The BE Journal of Economic Analysis & Policy, 21(2), 751–792.

26. DiNardo, J., & Lemieux, T. (2001). Alcohol, marijuana, and American youth: The unintended consequences of government regulation. Journal of Health Economics, 20(6), 991–1010.

27. Doleac, J. L., & Mukherjee, A. (2021). The effects of naloxone access laws on opioid abuse, mortality, and crime (August 12, 2021). https://doi.org/10.2139/ssrn.3135264.
    Paper not yet in RePEc: Add citation now
    
28. Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain–United States, 2016. JAMA, 315(15), 1624–1645.
    Paper not yet in RePEc: Add citation now
    
29. Ellis, R. J., Wang, Z., Genes, N., & Ma'ayan, A. (2019). Predicting opioid dependence from electronic health records with machine learning. BioData Mining, 12(1), 1–19.
    Paper not yet in RePEc: Add citation now
    

30. Evans, W. N., Lieber, E. M., & Power, P. (2019). How the reformulation of oxycontin ignited the heroin epidemic. Review of Economics and Statistics, 101(1), 1–15.

31. Forgionne, G. A., & Kohli, R. (1996). HMSS: A management support system for concurrent hospital decision making. Decision Support Systems, 16(3), 209–229.
    Paper not yet in RePEc: Add citation now
    
32. Haffajee, R. L., Jena, A. B., & Weiner, S. G. (2015). Mandatory use of prescription drug monitoring programs. JAMA, 313(9), 891–892.
    Paper not yet in RePEc: Add citation now
    
33. Haffajee, R. L., Mello, M. M., Zhang, F., Zaslavsky, A. M., Larochelle, M. R., & Wharam, J. F. (2018). Four states with robust prescription drug monitoring programs reduced opioid dosages. Health Affairs, 37(6), 964–974.
    Paper not yet in RePEc: Add citation now
    
34. Han, B., Compton, W. M., Jones, C. M., & Cai, R. (2015). Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the united states, 2003–2013. JAMA, 314(14), 1468–1478.
    Paper not yet in RePEc: Add citation now
    

35. Hansen, S., & Baroody, A. J. (2020). Electronic health records and the logics of care: Complementarity and conflict in the US healthcare system. Information Systems Research, 31(1), 57–75.

36. Harding, M., Leibtag, E., & Lovenheim, M. F. (2012). The heterogeneous geographic and socioeconomic incidence of cigarette taxes: Evidence from Nielsen Homescan data. American Economic Journal: Economic Policy, 4(4), 169–98.

37. Hollenbeck, B., & Uetake, K. (2021). Taxation and market power in the legal marijuana industry. The RAND Journal of Economics, 52(3), 559–595.

38. Holmgren, A. J., & Apathy, N. C. (2020). Evaluation of Prescription Drug Monitoring Program integration with hospital electronic health records by us county‐level opioid prescribing rates. JAMA Network Open, 3(6), e209085–e209085.
    Paper not yet in RePEc: Add citation now
    

39. Hydari, M. Z., Telang, R., & Marella, W. M. (2019). Saving Patient Ryan—Can advanced electronic medical records make patient care safer? Management Science, 65(5), 2041–2059.

40. Jacks, D. S., Pendakur, K., & Shigeoka, H. (2021). Infant mortality and the repeal of federal prohibition. The Economic Journal, 131(639), 2955–2983.

41. Jacobi, L., & Sovinsky, M. (2016). Marijuana on main street? Estimating demand in markets with limited access. American Economic Review, 106(8), 2009–2045.

42. Jones, S. S., Rudin, R. S., Perry, T., & Shekelle, P. G. (2014). Health information technology: An updated systematic review with a focus on meaningful use. Annals of Internal Medicine, 160(1), 48–54.
    Paper not yet in RePEc: Add citation now
    
43. Kellermann, A. L., & Jones, S. S. (2013). What it will take to achieve the as‐yet‐unfulfilled promises of health information technology. Health Affairs, 32(1), 63–68.
    Paper not yet in RePEc: Add citation now
    
44. Kelly, J. P., Cook, S. F., Kaufman, D. W., Anderson, T., Rosenberg, L., & Mitchell, A. A. (2008). Prevalence and characteristics of opioid use in the US adult population. Pain, 138(3), 507–513.
    Paper not yet in RePEc: Add citation now
    
45. Kreiner, P., Nikitin, R., & Shields, T. P. (2014). Bureau of Justice Assistance Prescription Drug Monitoring Program performance measures report: January 2009 through June 2012. U.S. Department of Justice, Bureau of Justice Assistance.
    Paper not yet in RePEc: Add citation now
    

46. Lovenheim, M. F. (2008). How far to the border?: The extent and impact of cross‐border casual cigarette smuggling. National Tax Journal, (pp. 7–33).

47. Lovenheim, M. F., & Slemrod, J. (2010). The fatal toll of driving to drink: The effect of minimum legal drinking age evasion on traffic fatalities. Journal of Health Economics, 29(1), 62–77.

48. Lu, S. F., Rui, H., & Seidmann, A. (2018). Does technology substitute for nurses? Staffing decisions in nursing homes. Management Science, 64(4), 1842–1859.

49. Mark Anderson, D., Hansen, B., & Rees, D. I. (2013). Medical marijuana laws, traffic fatalities, and alcohol consumption. The Journal of Law and Economics, 56(2), 333–369.

50. Mars, S. G., Bourgois, P., Karandinos, G., Montero, F., & Ciccarone, D. (2014). “Every ‘never’ I ever said came true”: Transitions from opioid pills to heroin injecting. International Journal of Drug Policy, 25(2), 257–266.
    Paper not yet in RePEc: Add citation now
    
51. Mars, S. G., Ondocsin, J., & Ciccarone, D. (2018). Toots, tastes and tester shots: User accounts of drug sampling methods for gauging heroin potency. Harm Reduction Journal, 15(1), 26.
    Paper not yet in RePEc: Add citation now
    

52. McCullough, J. S., Parente, S. T., & Town, R. (2016). Health information technology and patient outcomes: The role of information and labor coordination. The RAND Journal of Economics, 47(1), 207–236.

53. McMillan, G. P., & Lapham, S. (2006). Effectiveness of bans and laws in reducing traffic deaths: Legalized Sunday packaged alcohol sales and alcohol‐related traffic crashes and crash fatalities in New Mexico. American Journal of Public Health, 96(11), 1944–1948.
    Paper not yet in RePEc: Add citation now
    
54. Meara, E., Horwitz, J. R., Powell, W., McClelland, L., Zhou, W., O'Malley, A. J., & Morden, N. E. (2016). State legal restrictions and prescription‐opioid use among disabled adults. New England Journal of Medicine, 375(1), 44–53.
    Paper not yet in RePEc: Add citation now
    

55. Meldrum, M. L. (2016). The ongoing opioid prescription epidemic: Historical context. American Journal of Public Health, 106(8), 1365.

56. Merriman, D. (2010). The micro‐geography of tax avoidance: Evidence from littered cigarette packs in Chicago. American Economic Journal: Economic Policy, 2(2), 61–84.
    Paper not yet in RePEc: Add citation now
    

57. Miravete, E. J., Seim, K., & Thurk, J. (2018). Market power and the Laffer curve. Econometrica, 86(5), 1651–1687.

58. Miravete, E. J., Seim, K., & Thurk, J. (2020). One markup to rule them all: Taxation by liquor pricing regulation. American Economic Journal: Microeconomics, 12(1), 1–41.

59. Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016). Implementation of prescription drug monitoring programs associated with reductions in opioid‐related death rates. Health Affairs, 35(7), 1324–1332.
    Paper not yet in RePEc: Add citation now
    
60. PDMP TTAC (2015). Prescription Drug Monitoring Program training and technical assistance center. http://www.pdmpassist.org/content/state‐profiles.
    Paper not yet in RePEc: Add citation now
    

61. Powell, D., Pacula, R. L., & Jacobson, M. (2018). Do medical marijuana laws reduce addictions and deaths related to pain killers? Journal of Health Economics, 58, 29–42.

62. Rubin, D. B. (1986). Comment: Which ifs have causal answers. Journal of the American Statistical Association, 81(396), 961–962.
    Paper not yet in RePEc: Add citation now
    
63. Rudman, W., Corcoran, P., & Elliott, K. (2017). Prescription drug monitoring programs and opioid death rates. JAMA, 318(20), 2044–2044.
    Paper not yet in RePEc: Add citation now
    
64. Rutkow, L., Chang, H.‐Y., Daubresse, M., Webster, D. W., Stuart, E. A., & Alexander, G. C. (2015). Effect of Florida's prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Internal Medicine, 175(10), 1642–1649.
    Paper not yet in RePEc: Add citation now
    
65. SAMHSA. (2018). Medicaid coverage of medication‐assisted treatment for alcohol and opioid use disorders and of medication for the reversal of opioid overdose (HHS Publication No. SMA‐18‐5093). Substance Abuse and Mental Health Services Administration.
    Paper not yet in RePEc: Add citation now
    
66. Seiler, S., Tuchman, A., & Yao, S. (2021). The impact of soda taxes: Pass‐through, tax avoidance, and nutritional effects. Journal of Marketing Research, 58(1), 22–49.
    Paper not yet in RePEc: Add citation now
    
67. Shah, A., Hayes, C. J., & Martin, B. C. (2017). Characteristics of initial prescription episodes and likelihood of long‐term opioid use—United States, 2006–2015. Morbidity and Mortality Weekly Report, 66(10), 265.
    Paper not yet in RePEc: Add citation now
    

68. Sharma, L., Queenan, C., & Ozturk, O. (2019). The impact of information technology and communication on medical malpractice lawsuits. Production and Operations Management, 28(10), 2552–2572.

69. Sun, E. C., Darnall, B. D., Baker, L. C., & Mackey, S. (2016). Incidence of and risk factors for chronic opioid use among opioid‐naive patients in the postoperative period. JAMA Internal Medicine, 176(9), 1286–1293.
    Paper not yet in RePEc: Add citation now
    
70. UMSPH (2019). University of Michigan Behavioral Health Workforce Research Center and the National Council for Behavioral Health. Factors that influence access to medication‐assisted treatment. University of Michigan School of Public Health.
    Paper not yet in RePEc: Add citation now
    
71. Unick, G., Rosenblum, D., Mars, S., & Ciccarone, D. (2014). The relationship between US heroin market dynamics and heroin‐related overdose, 1992–2008. Addiction, 109(11), 1889–1898.
    Paper not yet in RePEc: Add citation now
    
72. Vivolo‐Kantor, A. M., Seth, P., Gladden, R. M., Mattson, C. L., Baldwin, G. T., Kite‐Powell, A., & Coletta, M. A. (2018). Vital signs: Trends in emergency department visits for suspected opioid overdoses—United States, July 2016–September 2017. Morbidity and Mortality Weekly Report, 67(9), 279.
    Paper not yet in RePEc: Add citation now
    
73. Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication‐assisted therapies—Tackling the opioid‐overdose epidemic. New England Journal of Medicine, 370(22), 2063–2066.
    Paper not yet in RePEc: Add citation now
    

74. Wang, P., Xiong, G., & Yang, J. (2019). Frontiers: Asymmetric effects of recreational cannabis legalization. Marketing Science, 38(6), 927–936.

75. Wang, Y., Lewis, M., & Singh, V. (2016). The unintended consequences of countermarketing strategies: How particular antismoking measures may shift consumers to more dangerous cigarettes. Marketing Science, 35(1), 55–72.

76. Winden, T. J., Boland, L. L., Frey, N., Satterlee, P. A., & Hokanson, J. S. (2014). Care everywhere, a point‐to‐point hie tool. Applied Clinical Informatics, 5(2), 388–401.
    Paper not yet in RePEc: Add citation now
    

77. Yaraghi, N., Du, A. Y., Sharman, R., Gopal, R. D., & Ramesh, R. (2015). Health information exchange as a multisided platform: adoption, usage, and practice involvement in service co‐production. Information Systems Research, 26(1), 1–18.

1. A Markovian score model for evaluating provider performance for continuity of care—An explainable analytics approach. (2024). Urban, Timothy L ; Yildirim, Mehmet B ; Topuz, Kazim.
   In: European Journal of Operational Research.
   RePEc:eee:ejores:v:317:y:2024:i:2:p:341-351.

   Full description at Econpapers || Download paper

2. Insurance Coverage and Provision of Opioid Treatment: Evidence from Medicare. (2023). Simon, Kosali ; Maclean, Johanna ; Cantor, Jonathan H ; Taylor, Erin ; Agniel, Denis.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:31884.

   Full description at Econpapers || Download paper

3. Multichannel Delivery in Healthcare: The Impact of Telemedicine Centers in Southern India. (2023). Ravilla, Thulasiraj ; Deo, Sarang ; Delana, Kraig ; Ramdas, Kamalini ; Subburaman, Ganesh-Babu B.
   In: Management Science.
   RePEc:inm:ormnsc:v:69:y:2023:i:5:p:2568-2586.

   Full description at Econpapers || Download paper

4. From prediction to decision: Optimizing long‐term care placements among older delayed discharge patients. (2023). Chuang, Yatang ; Ghazalbash, Somayeh ; Guilcher, Sara ; Samiedaluie, Saied ; Zargoush, Manaf ; Kuluski, Kerry.
   In: Production and Operations Management.
   RePEc:bla:popmgt:v:32:y:2023:i:4:p:1041-1058.

   Full description at Econpapers || Download paper

5. Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior. (2022). Grooms, Jevay ; Ellyson, Alice M ; Ortega, Alberto.
   In: Health Economics.
   RePEc:wly:hlthec:v:31:y:2022:i:2:p:297-341.

   Full description at Econpapers || Download paper

6. Lethal Unemployment Bonuses? Substitution and Income Effects on Substance Abuse, 2020-21. (2022). Mulligan, Casey.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:29719.

   Full description at Econpapers || Download paper

7. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
   In: IZA Discussion Papers.
   RePEc:iza:izadps:dp15221.

   Full description at Econpapers || Download paper

8. Curbing the Opioid Epidemic at Its Root: The Effect of Provider Discordance After Opioid Initiation. (2022). Scholtes, Stefan ; Freeman, Michael ; Huan, Lawrence ; Bobroske, Katherine ; Cattrell, Anita.
   In: Management Science.
   RePEc:inm:ormnsc:v:68:y:2022:i:3:p:2003-2015.

   Full description at Econpapers || Download paper

9. Opioids and the Labor Market. (2022). Schweitzer, Mark ; Fee, Kyle ; Aliprantis, Dionissi.
   In: Working Papers.
   RePEc:fip:fedcwq:180702.

   Full description at Econpapers || Download paper

10. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_9704.

    Full description at Econpapers || Download paper

11. Ancillary Cost Implications of Physicians Multisiting and Inter‐Organizational Collaboration During Healthcare Delivery. (2022). Lan, Yingchao ; Goradia, Deepa ; Chandrasekaran, Aravind.
    In: Production and Operations Management.
    RePEc:bla:popmgt:v:31:y:2022:i:2:p:561-582.

    Full description at Econpapers || Download paper

12. Electronic prescription monitoring and the opioid epidemic. (2022). Liu, Jiayi ; Kim, Ti Tongil ; Kc, Diwas.
    In: Production and Operations Management.
    RePEc:bla:popmgt:v:31:y:2022:i:11:p:4057-4074.

    Full description at Econpapers || Download paper

13. Are prescription drug monitoring laws effective for all? Evidence from administrative data. (2022). Gupta, Sumedha ; al Achkar, Morhaf ; Ray, Bradley.
    In: Contemporary Economic Policy.
    RePEc:bla:coecpo:v:40:y:2022:i:1:p:28-47.

    Full description at Econpapers || Download paper

14. Information Avoidance and Celebrity Exposure: The Effect of Magic Johnson on AIDS Diagnoses and Mortality in the U.S.. (2021). Martin, Joshua ; Rodriguez, Zachary ; Cardazzi, Alexander.
    In: Working Papers.
    RePEc:wvu:wpaper:21-04.

    Full description at Econpapers || Download paper

15. Prescription drug monitoring programs, opioid abuse, and crime. (2021). Horn, Brady ; Deza, Monica ; Dave, Dhaval.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:87:y:2021:i:3:p:808-848.

    Full description at Econpapers || Download paper

16. The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity. (2021). Wang, Lucy Xiaolu.
    In: Health Economics.
    RePEc:wly:hlthec:v:30:y:2021:i:9:p:2026-2046.

    Full description at Econpapers || Download paper

17. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2021). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29596.

    Full description at Econpapers || Download paper

18. Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation. (2021). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29574.

    Full description at Econpapers || Download paper

19. Illicit Drugs and the Decline of the Middle Class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp14035.

    Full description at Econpapers || Download paper

20. Labor Market Effects of the Oxycodone-Heroin Epidemic. (2021). Garcia, Daniel ; Cho, David ; Weingarden, Alison E.
    In: Finance and Economics Discussion Series.
    RePEc:fip:fedgfe:2021-25.

    Full description at Econpapers || Download paper

21. Thinking outside the box: The cross-border effect of tax cuts on R&D. (2021). Schwab, Thomas ; Todtenhaupt, Maximilian.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:204:y:2021:i:c:s0047272721001729.

    Full description at Econpapers || Download paper

22. Is the rise in illicit opioids affecting labor supply and disability claiming rates?. (2021). Powell, David ; Park, Sujeong.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629621000151.

    Full description at Econpapers || Download paper

23. Can policy affect initiation of addictive substance use? Evidence from opioid prescribing. (2021). Hollingsworth, Alex ; Nguyen, Thuy ; Simon, Kosali ; Sacks, Daniel W.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629620310432.

    Full description at Econpapers || Download paper

24. Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences. (2021). Kim, Bo Kyung.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:75:y:2021:i:c:s0167629620310547.

    Full description at Econpapers || Download paper

25. Illicit drugs and the decline of the middle class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:183:y:2021:i:c:p:718-743.

    Full description at Econpapers || Download paper

26. Designing interagency responses to wicked problems: Creating a common, cross-agency understanding. (2021). Sydelko, Pamela ; Midgley, Gerald ; Espinosa, Angela.
    In: European Journal of Operational Research.
    RePEc:eee:ejores:v:294:y:2021:i:1:p:250-263.

    Full description at Econpapers || Download paper

27. Can electronic prescribing mandates reduce opioid-related overdoses?. (2021). Powell, David ; Abouk, Rahi.
    In: Economics & Human Biology.
    RePEc:eee:ehbiol:v:42:y:2021:i:c:s1570677x21000241.

    Full description at Econpapers || Download paper

28. The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime. (2021). Giua, Ludovica ; Ludovica, Giua ; Claudio, Deiana.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:21:y:2021:i:2:p:751-792:n:11.

    Full description at Econpapers || Download paper

29. Breaking the Crystal Methamphetamine Economy: Illegal Drugs, Supply‐side Interventions and Crime Responses. (2021). d'Este, Rocco.
    In: Economica.
    RePEc:bla:econom:v:88:y:2021:i:349:p:208-233.

    Full description at Econpapers || Download paper

30. When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic. (2021). Glaeser, Edward L ; Cutler, David M.
    In: Journal of Economic Perspectives.
    RePEc:aea:jecper:v:35:y:2021:i:4:p:171-96.

    Full description at Econpapers || Download paper

31. How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program. (2020). Buchmueller, Thomas C ; Meille, Giacomo ; Carey, Colleen M.
    In: Health Economics.
    RePEc:wly:hlthec:v:29:y:2020:i:9:p:957-974.

    Full description at Econpapers || Download paper

32. Drugs on the Web, Crime in the Streets - The Impact of Dark Web Marketplaces on Street Crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucn:wpaper:202025.

    Full description at Econpapers || Download paper

33. Drugs on the Web, Crime in the Streets. The impact of Dark Web marketplaces on street crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucd:wpaper:202009.

    Full description at Econpapers || Download paper

34. Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?. (2020). Powell, David ; Park, Sujeong.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27804.

    Full description at Econpapers || Download paper

35. Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws. (2020). Simon, Kosali ; Gupta, Sumedha ; Nguyen, Thuy D ; Freeman, Patricia R.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27520.

    Full description at Econpapers || Download paper

36. Three Myths about Federal Regulation. (2020). Mulligan, Casey ; McLaughlin, Patrick A.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27233.

    Full description at Econpapers || Download paper

37. Paid sick-leave and physical mobility: Evidence from the United States during a pandemic. (2020). Simon, Kosali ; Pesko, Michael ; Maclean, Johanna ; Andersen, Martin.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27138.

    Full description at Econpapers || Download paper

38. The Evolving Consequences of OxyContin Reformulation on Drug Overdoses. (2020). Powell, David ; Pacula, Rosalie.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26988.

    Full description at Econpapers || Download paper

39. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26812.

    Full description at Econpapers || Download paper

40. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2020-10.

    Full description at Econpapers || Download paper

41. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp13395.

    Full description at Econpapers || Download paper

42. Retail Pharmacies and Drug Diversion during the Opioid Epidemic. (2020). Zhang, Xuan ; Janssen, Aljoscha.
    In: Working Paper Series.
    RePEc:hhs:iuiwop:1373.

    Full description at Econpapers || Download paper

43. The relationship of opioid prescriptions and the educational performance of children. (2020). Ozturk, Orgul ; Gordanier, John M ; Cotti, Chad D.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620306250.

    Full description at Econpapers || Download paper

44. Umbrella branding in pharmaceutical markets. (2020). Suppliet, Moritz.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:73:y:2020:i:c:s0167629619303856.

    Full description at Econpapers || Download paper

45. How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D. (2020). Powell, David ; Pacula, Rosalie ; Taylor, Erin.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619303029.

    Full description at Econpapers || Download paper

46. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey B.
    In: Working Papers.
    RePEc:bfi:wpaper:2020-10.

    Full description at Econpapers || Download paper

47. Shackling the Identification Police?. (2019). Ruhm, Christopher.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:85:y:2019:i:4:p:1016-1026.

    Full description at Econpapers || Download paper

48. Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision. (2019). Wettstein, Gal.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:5:p:666-677.

    Full description at Econpapers || Download paper

49. Adverse health effects of abuse‐deterrent opioids: Evidence from the reformulation of OxyContin. (2019). Beheshti, David.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:12:p:1449-1461.

    Full description at Econpapers || Download paper

50. How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs. (2019). Simon, Kosali ; Bradford, W. David ; Nguyen, Thuy D.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26356.

    Full description at Econpapers || Download paper

51. Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing. (2019). Simon, Kosali ; Hollingsworth, Alex ; Nguyen, Thuy D ; Sacks, Daniel W.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25974.

    Full description at Econpapers || Download paper

52. A novel supply-side measure to combat abuse of addictive prescription drugs. (2019). Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2019_11.

    Full description at Econpapers || Download paper

53. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Bockerman, Petri ; Saxell, Tanja.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp12275.

    Full description at Econpapers || Download paper

54. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Saxell, Tanja ; Bockerman, Petri.
    In: Working Papers.
    RePEc:fer:wpaper:117.

    Full description at Econpapers || Download paper

55. Drivers of the fatal drug epidemic. (2019). Ruhm, Christopher.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:64:y:2019:i:c:p:25-42.

    Full description at Econpapers || Download paper

56. Shackling the Identification Police?. (2018). Ruhm, Christopher.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25320.

    Full description at Econpapers || Download paper

57. Too much cocited documents. This list is not complete

Report date: 2025-09-23 03:25:09 || Missing content? Let us know